MedPath
NMPA Approval

Ketotifen Fumarate Oral Solution

国药准字H20254155

May 13, 2025

Drug Information

富马酸酮替芬口服溶液

口服溶液剂

150ml:30mg(按C₁₉H₁₉NOS计)

化学药品

May 13, 2025

Company Information

Applicant Company

海南省海口市国家高新技术产业开发区药谷工业园(二期)药谷一横路16号1#厂房第三层东侧区域

Manufacturing Company

海口国家高新区药谷工业园二期内

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

富马酸酮替芬口服溶液 - NMPA 批准文号 | MedPath